Putamen Hypertrophy in Nondemented Patients With Human Immunodeficiency Virus Infection and Cognitive Compromise

Authors:

Abstract
The basal ganglia (BG) and hippocampus are selectively vulnerable to the human immunodeficiency virus (HIV).1-3 Several studies document BG atrophy in late-stage HIV infection and patients with HIV dementia,4-6 but the patterns of subcortical volume change in early stages of the illness remain unclear. Although there is evidence of BG atrophy in nondemented patients with HIV,7 other studies of patients who are seropositive for HIV (HIV+ patients) in asymptomatic disease stages4 and with motor dysfunction8 fail to replicate these findings. The variability in cognitive assessment methods of HIV+ patients and definition of neuroanatomic regions of interest (ROIs) contributes to the inconsistency of the findings across studies.

This publication has 17 references indexed in Scilit: